The labeling for Ortho Evra (norelgestromin/ethinyl estradiol transdermal patch, from Ortho-McNeil) has been updated to include additional safety data regarding an increased risk of venous ...

Statement to NBC News from a representative of Johnson & Johnson in response to a report about the Ortho Evra birth control patch. Below is a statement to NBC News from a Johnson & Johnson ...

The FDA announced a revision to the labeling for the Ortho Evra birth-control patch, warning that women taking the drug may be exposed to 60% more estrogen than if they were taking a typical 35 ...

The U.S. Food and Drug Administration approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that ...

September 21, 2006 — The US Food and Drug Administration (FDA) and Ortho-McNeil Pharmaceutical (a Johnson & Johnson company) have notified healthcare professionals regarding changes to the safety ...

On November 10, 2005, Ortho McNeil, in conjunction with the FDA, issued a warning about the increased risks of blood clots associated with Ortho Evra. In the new warning, Ortho-McNeil admitted for the ...

The maker and distributor of a widely used once-a-week birth control patch were the targets of lawsuits filed Wednesday in San Francisco by the mother of a 25-year-old woman who died after using the ...

More than 40 women sued the makers of a popular birth-control patch Wednesday, claiming the contraceptive caused serious illnesses and at least one death. One lawsuit alleges that 43 women suffered ...

Public Citizen petitions the FDA, claiming the patch poses serious health risks. May 8, 2008— -- A consumer advocacy group petitioned the government Thursday to pull the birth-control patch off ...

The Food and Drug Administration warned users of the popular Ortho Evra birth control patch that they are being exposed to more hormones, and are therefore at higher risk of blood clots and other ...

The makers of a popular birth-control patch warned millions of women Thursday that the patch exposes them to significantly higher doses of hormones and may put them at greater risk for blood clots and ...